Andrew E. Goldsmith

Andrew E. Goldsmith is a litigator at Kellogg, Hansen, Todd, Figel & Frederick P.L.L.C., where he represents clients across a diverse range of complex litigation, including patent, antitrust, securities, and False Claims Act matters. His patent litigation practice frequently involves pharmaceutical and biologics technology, as evidenced by his lead counsel role in cases concerning the Biologics Price Competition and Innovation Act (BPCIA). He also has experience with technology-related patent disputes before the International Trade Commission (ITC), having successfully represented a complainant in obtaining a general exclusion order related to high-density fiber optic equipment.

While Mr. Goldsmith's tracked patent litigation experience primarily reflects plaintiff-side representation, such as in Regeneron Pharmaceuticals, Inc. v. Sandoz Inc., his broader practice includes representing both plaintiffs and defendants across various industries. He has demonstrated significant trial acumen in high-stakes commercial litigation, including securing a $147.4 million antitrust jury verdict (trebled to $442.2 million) for Innovative Health against Biosense Webster and achieving a defense verdict for Meta Platforms in an antitrust case brought by the Federal Trade Commission.

A notable aspect of his patent work includes his involvement in Regeneron's extensive Eylea® patent enforcement campaign, which has resulted in settlements and preliminary injunctions against biosimilar manufacturers. While Kellogg Hansen's intellectual property practice handles Patent Office proceedings, specific information regarding Mr. Goldsmith's regular appearances in Inter Partes Review (IPR) or Post-Grant Review (PGR) proceedings is not readily available.

Mr. Goldsmith earned his J.D., cum laude, from Harvard Law School in 2004 and an A.B., with Highest Honors in History, from Brown University in 1999. He also served as a law clerk for Judge Reena Raggi on the U.S. Court of Appeals for the Second Circuit and as an Assistant U.S. Attorney for the Eastern District of New York. He was admitted to practice in 2005.